CASI icon

CASI Pharmaceuticals
CASI

Overview Fund Activity

45 hedge funds and large institutions have $18.9M invested in CASI Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 14 reducing their positions, and 10 closing their positions.

Holders
45
Holders Change
-6
Holders Change %
-11.76%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
7
Reduced
14
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
WSC
1
Wellington Shields & Co
New York
$1.18M
2
Citadel Advisors
2
Citadel Advisors
Florida
$124K
3
IC
3
Ikarian Capital
Texas
$1.07M
4
Citigroup
4
Citigroup
New York
$59K
5
VF
5
Virtu Financial
New York
$91K

Top Sellers

1
Jacobs Levy Equity Management
1
Jacobs Levy Equity Management
New Jersey
$0
2
Renaissance Technologies
2
Renaissance Technologies
New York
$126K
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$2.48M
4
Marshall Wace
4
Marshall Wace
United Kingdom
$0
5
AFM
5
Anson Funds Management
Texas
$0
Name Market Value Shares Shares
Change 		Shares
Change %
SWM
51
Selective Wealth Management
Virginia
$0 5 – –
JPMorgan Chase & Co
52
JPMorgan Chase & Co
New York
$0 258 – –
CFGS
53
Concourse Financial Group Securities
Alabama
– – – –
Northwestern Mutual Wealth Management
54
Northwestern Mutual Wealth Management
Wisconsin
$0 132 – –
Royal Bank of Canada
55
Royal Bank of Canada
Ontario, Canada
$0 181 – –
JPLA
56
Joseph P. Lucia & Associates
New York
$0 1 +1 New
1 2
3